Involvement of the endogenous opioid system in the beneficial influence of physical exercise on amphetamine-induced addiction parameters

Copyright © 2020 Elsevier Inc. All rights reserved..

Psychostimulant drugs addiction is a chronic public health problem and individuals remain susceptible to relapses increasing public expenses even after withdrawal and treatment. Our research group has focused on finding new therapies to be employed in drug addiction treatment, suggesting the physical exercise as a promising tool. This way, it is necessary to know the mechanisms involved in the beneficial influences of physical exercise observing the pathway that could be explored in drug addiction treatment. Male Wistar rats were conditioned with amphetamine (AMPH) following the conditioned place preference (CPP) protocol and subsequently submitted to swimming for 5 weeks (1 h per day, 5 days per week). Half of the animals were injected with Naloxone (0.3 mg/mL/kg body weight, i.p.) 5 min prior each physical exercise day. After AMPH-CPP re-exposure, our outcomes showed that physical exercise, in addition to minimizing the relapse behavior in the CPP, it increased D1R, D2R and DAT in the Ventral Tegmental Area (VTA), but not in the Nucleus accumbens (NAc). Interestingly, while naloxone inhibited the partial beneficial influence of the exercise on drug-relapse behavior, exercise-induced changes in the dopaminergic system were not observed in the group administered with naloxone as well. Based on these evidences, besides reinforcing the beneficial influence of the physical exercise on AMPH-induced drug addiction, we propose the involvement of endogenous opioid system activation, not as a single one, but as a possible mechanism of action resulting from the physical activity practice, thus characterizing an important therapeutic approach, which may contribute to drug withdrawal consequently preventing relapse.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:197

Enthalten in:

Pharmacology, biochemistry, and behavior - 197(2020) vom: 10. Okt., Seite 173000

Sprache:

Englisch

Beteiligte Personen:

Rosa, H Z [VerfasserIn]
Segat, H J [VerfasserIn]
Barcelos, R C S [VerfasserIn]
Roversi, Kr [VerfasserIn]
Rossato, D R [VerfasserIn]
de Brum, G F [VerfasserIn]
Burger, M E [VerfasserIn]

Links:

Volltext

Themen:

36B82AMQ7N
Amphetamine
CK833KGX7E
Central Nervous System Stimulants
DRD2 protein, rat
Dopamine Plasma Membrane Transport Proteins
Dopaminergic system
Drd1 protein, rat
Drug addiction
Journal Article
Mesolimbic region
Naloxone
Narcotic Antagonists
Psychostimulant
Receptors, Dopamine D1
Receptors, Dopamine D2
Relapse
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 08.02.2021

Date Revised 08.02.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.pbb.2020.173000

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM312784147